Parkinson's Disease Trial, Recruiting NCT04426786 Sponsor: Pacific Parkinson's Research Centre Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT04426786
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People diagnosed with idiopathic (standard) Parkinson's disease, including those with a family history of the condition, based on a recognised set of diagnostic guidelines (UK Brain Bank criteria)
  • People with mild to moderate Parkinson's symptoms, rated at stages 1 to 3 on a standard scale (Hoehn & Yahr)
  • People who currently exercise less than 120 minutes per week

Who may not be able to join:

  • People with an atypical form of Parkinsonism, such as progressive supranuclear palsy, multiple system atrophy, or Parkinsonism caused by medication
  • People with significant osteoporosis or arthritis
  • People who have had cancer within the last 5 years
  • People who have had a high dose of radiation from medical procedures within the past year
  • People who are unable to pause their Parkinson's medication for up to 24 hours
  • People who are currently pregnant or breastfeeding
  • People with a current or past history of substance use problems
  • People who have had a serious head injury involving loss of consciousness for 5 minutes or more
  • People living with certain chronic conditions, including diabetes, kidney disease, high blood pressure, heart disease, or other known neurological disorders
  • People with a significant breathing condition such as asthma or COPD, or who use home oxygen
  • People with a current or past neurological disorder other than Parkinson's disease, such as stroke or seizures
  • People with a current or past psychiatric disorder, such as depression or anxiety
  • People with severe claustrophobia (a strong fear of enclosed spaces)
  • People who weigh more than 158 kg (347 lbs)
  • People who are unable to lie still for up to 90 minutes
  • People who have not been medically cleared to exercise
  • People taking certain medications or living with certain conditions that may affect participation — these cases would be reviewed individually with the study team (confirm with trial site)
  • People who work as machinists or metalworkers
  • People with a cardiac pacemaker, heart wires, or a defibrillator implanted in the body
  • People with a history of a metal fragment lodging in or around the eye
  • People with a ferromagnetic aneurysm clip in the brain or body
  • People with an artificial heart valve
  • People with an electrical stimulator implanted for nerves or bones
  • People with an ear or eye implant
  • People with an implanted drug infusion pump
  • People with a coil, catheter, or filter inside a blood vessel
  • People with orthopaedic hardware such as an artificial joint, metal plate, or screws
  • People with other metallic prostheses
  • People with shrapnel, bullets, or other metal fragments in the body
  • People who wear dentures, braces, or a retainer
  • People who have had brain or other surgery, tattoos, or a joint injection within the last 6 weeks
  • People with pierced body parts other than ears, or tattooed eyeliner
  • People with a non-MRI-safe intrauterine device (IUD)
  • People found to have significant cognitive impairment or depression following enrolment
  • People found to have significant or unstable heart or breathing disease, identified through a screening exercise test
  • People who do not complete at least 60 of the 72 scheduled exercise classes during the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Vesna Sossi, University of British Columbia

Phone: 604 822 7764

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Pacific Parkinson's Research Centre
Registry
ClinicalTrials.gov
Start date
26 January 2021
Est. completion
30 December 2025

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

PET/MRI

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov